June 29, 2020 / 8:38 AM / 7 days ago

BRIEF-Initiator Pharma Gets Approval To Start Phase 2a Trial For IP2018

June 29 (Reuters) - Initiator Pharma A/S:

* INITIATOR PHARMA OBTAINS APPROVAL TO START PHASE 2A TRIAL FOR IP2018

* IP2018. PHASE 2A CLINICAL TRIAL IS PLANNED TO BE INITIATED IN Q3 2020

* PENDING COVID-19 SITUATION TRIAL IS PLANNED TO START IN Q3 2020 AND TOP-LINE DATA IS EXPECTED END OF FIRST HALF YEAR OF 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below